Mawita Suanbani, . (2020) PERBEDAAN KEJADIAN REINFARK MIOKARD AKIBAT PENGGUNAAN ANTIKOAGULAN UFH DAN ENOXAPARIN PADA PASIEN STEMI : TINJAUAN PUSTAKA SISTEMATIS. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.
Text
ABSTRAK.pdf Download (314kB) |
|
Text
AWAL.pdf Download (622kB) |
|
Text
BAB 1.pdf Download (107kB) |
|
Text
BAB 2.pdf Restricted to Repository UPNVJ Only Download (500kB) |
|
Text
BAB 3.pdf Restricted to Repository UPNVJ Only Download (572kB) |
|
Text
BAB 4.pdf Restricted to Repository UPNVJ Only Download (332kB) |
|
Text
BAB 5.pdf Download (320kB) |
|
Text
DAFTAR PUSTAKA.pdf Download (408kB) |
|
Text
RIWAYAT HIDUP.pdf Restricted to Repository UPNVJ Only Download (216kB) |
|
Text
LAMPIRAN.pdf Restricted to Repository UPNVJ Only Download (550kB) |
|
Text
ARTIKEL KI.pdf Restricted to Repository UPNVJ Only Download (299kB) |
Abstract
Conditions myocardial infarction with STEMI requires revascularization treatment immediately. Pharmacologically enoxaparin is better than UFH because it less activates platelets that can induce Heparin Induced Thrombocytopenia or HIT. This condition is potentially lethal and one of the complications is acute myocardial infarction. The method of this research used Systematic Review, a method used to gather relevant evidence in accordance with the pre-determined eligibility criteria to answer the research question that becomes focus of the researches. Journal quality assessments was using The Cochrane Collaboration‟s Tool for Assessing Risk of Bias. Total of 36.778 patients with STEMI received anticoagulant therapy, 18.395 patients were taking enoxaparin and 18.383 patients were taking UFH or heparin. Total 23.255 patients received other fibrinolytic therapy as initial management for STEMI, patients were then randomized to receive enoxaparin or heparin therapy. Enoxaparin was better in inhibiting coagulation cascade than UFH, it was effective in preventing HIT, and also had a longer half-life and be able to suppress the von Willebrand factor. There were significant difference in myocardial reinfarction due to application of anticoagulant UFH and enoxaparin regardless of initial treatment. Keyword : Myocardial infarction, LMWH, UFH
Item Type: | Thesis (Skripsi) |
---|---|
Additional Information: | [No. Panggil : 1610211014] [Pembimbing: Citra Ayu Aprilia] [Penguji 1: Kristina Simanjuntak] |
Uncontrolled Keywords: | Myocardial infarction, LMWH, UFH |
Subjects: | R Medicine > RZ Other systems of medicine |
Divisions: | Fakultas Kedokteran > Program Studi Kedokteran (S1) |
Depositing User: | Mawita Suanbani |
Date Deposited: | 16 Sep 2022 03:29 |
Last Modified: | 16 Sep 2022 03:29 |
URI: | http://repository.upnvj.ac.id/id/eprint/7355 |
Actions (login required)
View Item |